SEMA3E and prostate cancer: While other studies have reported Sema3E to have inhibitory effects on melanoma and prostate cancer metastasis [25, 31], they failed to identify and discriminate between the full-length and the cleaved forms of the protein, making it difficult to discern between distinct differences between types of cancer or Sema3E cleavage.